pharmaphorum

OCTOBER 3, 2022

The third ALS treatment to be given FDA approval, following Mitsubishi Tanabe’s Radicava ($170,000 per year) and generic drug riluzole – Relyvrio is priced at around $12,500 per 28-day prescription. Clearer’ data isn’t expected until 2024, with results from a late-stage phase 3 PHOENIX trial of around 600 patients due at that time.

Insurance 52

Insurance Prescription FDA Patients 52

pharmaphorum

SEPTEMBER 30, 2022

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year.

FDA 84

FDA Doctors Patients Prescription 84

PM360

NOVEMBER 13, 2023

Improving healthcare and patient outcomes requires that stakeholders communicate and collaborate, and GoodRx is one of the few places where providers, patients, and pharma can connect every single day. 3 For those who think trust is a “soft” metric, here are some hard numbers. How are they different?

Media 52

Media Prescription Healthcare Provider Patients 52

PM360

SEPTEMBER 21, 2023

This product would be a more potent prescription version than the OTCs, Casberg notes. The product, manufactured by ARS Pharma and Neurelis Pharma, would be the first needle-free epinephrine alternative to autoinjectors, such as the EpiPen. In 2024, ARPA removes the 100% AMP cap.

Management 105

Management Manufacturing Sales Competition 105

Clarivate

DECEMBER 19, 2022

Insurers that incentivize using Walmart facilities in Medicare Advantage and prescription drug plans (PDPs) have seen success; Humana has a long-running standalone Part D plan with Walmart pharmacies as preferred network locations.

Competition 52

Competition Retail Insurance Marketing 52

Clarivate

MAY 13, 2024

According to Clarivate’s latest enrollment data, as of January 2024, Medicaid enrollment had plummeted by nearly 9 million compared to six months prior. For 2024, 18% of enrollees were new to exchange coverage, according to the Centers for Medicare and Medicaid Services. million between January 2023 and January 2024. to about 2.5

Insurance 52

Insurance Marketing Healthcare Healthcare 52

PM360

DECEMBER 20, 2023

A significant battle for the hearts and minds of healthcare professionals (HCPs) will play out in social media during 2024. Fifty percent of responders said they changed prescriptions because of social media information. million self-identified HCPs on the platform to pharma marketers. Look for TikTok to merchandise the 4.7

Media 122

Media Physicians Pharma reps Pharma Rep 122

Pharmaceutical Technology

JANUARY 16, 2023

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. The entire pharma industry will be affected by the fallout.

Pharma 64

Pharma Manufacturing Pharmaceutical Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. The entire pharma industry will be affected by the fallout.

Pharma 52

Pharma Manufacturing Pharmaceutical Marketing 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Samsung Bioepis and Organon previously stated that Hadlima's interchangeability data should be ready in 2024.

Marketing 104

Marketing Physicians Competition Patients 104

World of DTC Marketing

MARCH 30, 2022

Roughly 1 in 4 adults report difficulty affording their prescription drugs, according to KFF polling. in traditional categories like hospitals, prescription drugs and doctors, and clinical services through 2024, while pandemic-related effects like COVID vaccines, testing and treatment, and expanded Medicaid coverage fall off.

Pharma 189

Pharma Prescription Insurance Doctors 189

Pharmaceutical Technology

DECEMBER 2, 2022

After the mid-term election results, former President Donald Trump also announced his intention to run for re-election in the 2024 presidential election. If appointed to the role, Sanders will focus on universal healthcare and influencing the costs of prescription drugs.

Pharma 59

Pharma Government Healthcare Healthcare 59